Please assess the completion status of the following clinical trial:

Trial Title: Intravenous Versus Oral Administration of Prednisolone in Exacerbations of Chronic Obstructive Pulmonary Disease (COPD)

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE4
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Exacerbation of COPD (at least Global Initiative for Chronic Obstructive Lung Disease \[GOLD\] severity stage II)~* Smoking history of \> 10 pack years~Exclusion Criteria:~* Signs of severe exacerbation (arterial pH \< 7.26 or pCO2 \> 9.3 kPa)~* History of asthma~* Significant or unstable co-morbidity~* Participated in another study 4 weeks before admission~* Previously randomized to this study~* Findings on chest radiography other than those fitting with signs of COPD~* Known hypersensitivity to prednisolone~* Non-compliant

- Gender: ALL
- Minimum Age: 40 Years
- Maximum Age: None
- Healthy Volunteers: None

Based on this trial design, predict the completion outcome and termination type (if applicable).